These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 3244653)

  • 21. Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration.
    Supersaxo A; Hein WR; Steffen H
    Pharm Res; 1990 Feb; 7(2):167-9. PubMed ID: 2137911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of interferon-alpha-2a on the output of recirculating lymphocytes from single lymph nodes.
    Hein WR; Supersaxo A
    Immunology; 1988 Jul; 64(3):469-74. PubMed ID: 3410492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of recombinant leukocyte A interferon following various routes and modes of administration to the dog.
    Gibson DM; Cotler S; Spiegel HE; Colburn WA
    J Interferon Res; 1985; 5(3):403-8. PubMed ID: 4056487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I trial of 5-fluorouracil and recombinant alpha 2a-interferon in patients with advanced colorectal carcinoma.
    Wadler S; Goldman M; Lyver A; Wiernik PH
    Cancer Res; 1990 Apr; 50(7):2056-9. PubMed ID: 2317795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma.
    Grem JL; McAtee N; Murphy RF; Balis FM; Steinberg SM; Hamilton JM; Sorensen JM; Sartor O; Kramer BS; Goldstein LJ
    J Clin Oncol; 1991 Oct; 9(10):1811-20. PubMed ID: 1919632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The physiological interferon response.
    Bocci V
    Immunol Today; 1985 Jan; 6(1):7-9. PubMed ID: 25291198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation of enteral absorption of human interferon alpha and selective transfer into lymphatics in rats.
    Yoshikawa H; Takada K; Satoh Y; Naruse N; Muranishi S
    Pharm Res; 1985 Sep; 2(5):249-50. PubMed ID: 24272847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of Interferon Suppositories. I. Enhanced Rectal Absorption of Human Fibroblast Interferon by Fusogenic Lipid via Lymphotropic Delivery in Rats.
    Yoshikawa H; Takada K; Satoh Y; Naruse N; Muranishi S
    Pharm Res; 1986 Apr; 3(2):116-7. PubMed ID: 24271471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. THE ORIGIN OF THE CELLS IN THE EFFERENT LYMPH FROM A SINGLE LYMPH NODE.
    HALL JG; MORRIS B
    J Exp Med; 1965 Jun; 121(6):901-10. PubMed ID: 14319406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The output of cells in lymph from the popliteal node of sheep.
    HALL JG; MORRIS B
    Q J Exp Physiol Cogn Med Sci; 1962 Oct; 47():360-9. PubMed ID: 13952111
    [No Abstract]   [Full Text] [Related]  

  • 31. [Interferon: A greatly simplified immuno enzyme determination with two monoclonal antibodies].
    Gallati H
    J Clin Chem Clin Biochem; 1982 Dec; 20(12):907-14. PubMed ID: 6763622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A method to potentiate enteral absorption of interferon and selective delivery into lymphatics.
    Yoshikawa H; Takada K; Muranishi S; Satoh Y; Naruse N
    J Pharmacobiodyn; 1984 Jan; 7(1):59-62. PubMed ID: 6726613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human interferons--from protein purification and sequence to cloning and expression in bacteria: before, between, and beyond.
    Pestka S
    Arch Biochem Biophys; 1983 Feb; 221(1):1-37. PubMed ID: 6187286
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of routes of administration of interferon in cancer: a review and a proposal.
    Bocci V
    Cancer Drug Deliv; 1984; 1(4):337-51. PubMed ID: 6085757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of disappearance from blood and lymphatic delivery of human fibroblast interferon in rat by different administration routes.
    Yoshikawa H; Satoh Y; Naruse N; Takada K; Muranishi S
    J Pharmacobiodyn; 1985 Mar; 8(3):206-10. PubMed ID: 4009412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lymphatic route. 1) Albumin and hyaluronidase modify the normal distribution of interferon in lymph and plasma.
    Bocci V; Muscettola M; Grasso G; Magyar Z; Naldini A; Szabo G
    Experientia; 1986 Apr; 42(4):432-3. PubMed ID: 3956696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The lymphatic route--II. Pharmacokinetics of human recombinant interferon-alpha 2 injected with albumin as a retarder in rabbits.
    Bocci V; Muscettola M; Naldini A; Bianchi E; Segre G
    Gen Pharmacol; 1986; 17(1):93-6. PubMed ID: 3949153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lymphatic route--III. Pharmacokinetics of human natural interferon-beta injected with albumin as a retarder in rabbits.
    Bocci V; Muscettola M; Naldini A
    Gen Pharmacol; 1986; 17(4):445-8. PubMed ID: 3758650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The preclinical development of Roferon-A.
    Trown PW; Wills RJ; Kamm JJ
    Cancer; 1986 Apr; 57(8 Suppl):1648-56. PubMed ID: 3081245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulators as local hormones: new insights regarding their clinical utilization.
    Bocci V
    J Biol Response Mod; 1985 Aug; 4(4):340-52. PubMed ID: 2411878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.